Central Trust Company’s iShares iBonds Dec 2034 Term Corporate ETF IBDZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.1K Sell
888
-10
-1% -$260 ﹤0.01% 1039
2026
Q1
$23.4K Sell
898
-41
-4% -$1.08K ﹤0.01% 981
2025
Q4
$24.8K Buy
939
+44
+5% +$1.16K ﹤0.01% 938
2025
Q3
$23.7K Sell
895
-55
-6% -$1.44K ﹤0.01% 950
2025
Q2
$24.8K Sell
950
-17
-2% -$434 ﹤0.01% 941
2025
Q1
$24.9K Buy
967
+6
+0.6% +$153 ﹤0.01% 933
2024
Q4
$24.5K Buy
+961
New +$24.9K ﹤0.01% 932

Other funds holding IBDZ

Central Trust Company's IBDZ Position: Q2 2026 in Review

Central Trust Company reduced its iShares iBonds Dec 2034 Term Corporate ETF (IBDZ) stake by 1.1% in Q2 2026, selling an estimated $260 and leaving 888 shares worth $23.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1039.

Central Trust Company first reported a position in IBDZ in Q4 2024 and has held it in 7 quarters since. The position peaked at $24.9K in Q1 2025. 57 funds tracked by Wall St. Rank hold IBDZ as of Q2 2026.

  • Central Trust Company held 888 shares of iShares iBonds Dec 2034 Term Corporate ETF worth $23.1K as of Q2 2026.
  • Central Trust Company sold 10 iShares iBonds Dec 2034 Term Corporate ETF shares in Q2 2026, an estimated $260.
  • iShares iBonds Dec 2034 Term Corporate ETF made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #1039 holding.
  • Central Trust Company first reported a position in iShares iBonds Dec 2034 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • Central Trust Company's iShares iBonds Dec 2034 Term Corporate ETF position peaked at $24.9K in Q1 2025.
  • 57 funds tracked by Wall St. Rank held iShares iBonds Dec 2034 Term Corporate ETF as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.